Board Meeting14 Aug 2026, 07:11 pm
Auro Laboratories Board Approves Unaudited Q1 FY27 Results
AI Summary
Auro Laboratories Limited announced the outcome of its Board Meeting held on August 14, 2026. The Board approved the Unaudited Financial Results for the quarter ended June 30, 2026. The results were recommended by the Audit Committee and have been prepared in accordance with Indian Accounting Standards (IndAS 34). The company operates in a single segment, Pharmaceuticals. The financial results will be published in newspapers in due course.
Key Highlights
- Board approved unaudited financial results for Q1 FY27.
- Results recommended by the Audit Committee.
- Prepared as per Indian Accounting Standards (IndAS 34).
- Company operates in a single segment: Pharmaceuticals.
- Results to be published in newspapers shortly.
Price Impact
More from AUROLAB